Table 1.
Patient characteristics (n=47)
| Characteristic | |
|---|---|
|
Mean age (years) (SD) |
39 (8.7) |
|
Sex |
|
| Male, n (%) |
30 (63.8)* |
|
HIV infection & Antiretroviral treatment |
|
| Median nadir CD4 count (cells/μL) (IQR) |
153 (85–247) |
| Median CD4 count at the time of evaluation (cells/μL) (IQR) |
264 (158–361) |
| HIV viral load undetectable (<20 copies/μL) at the time of evaluation, n (%) |
34 (72.3) |
| Median duration of antiretroviral treatment (months) (IQR) |
17.5 (4–32.5) |
|
Tuberculosis and anti-TB treatment |
|
| Multidrug-resistant TB (MDR-TB), n (%) |
44 (93.6) |
| Extensively and extremely drug-resistant TB (XDR & XXDR-TB), n (%) |
3 (6.4) |
| Extra-pulmonary TB |
14 (29.8) |
| Median duration of anti-TB treatment (months) (IQR) | 13 (4–21) |
* Two biological males were transgender.